Comparing the efficacy of endoscopic endonasal versus microscopic transsphenoidal approach for the management of sellar and suprasellar tumors: a systematic review and meta-analysis protocol

Author:

Tango Tamara1,Daniel Jeremiah Oluwatomi Itodo2ORCID,Mugenyi Nathan3ORCID,Abongha Gobti Beltus4,Mesfin Samuel5,Javed Saad6,Omran Murad Othman7,Eltingary Mazin M8,Kyaruzi Victor Meza9ORCID

Affiliation:

1. Faculty of Medicine Universitas Indonesia Faculty of Medicine, , Jakarta , Indonesia

2. Faculty of Clinical Sciences, College of Health Sciences, Obafemi Awolowo University , Ile-Ife , Nigeria

3. Mbarara University of Science and Technology Faculty of Medicine, , Mbarara , Uganda

4. University of Bamenda Faculty of Health Sciences, , Bamenda , Cameroon

5. Addis Ababa University College of Health Sciences, , Addis Ababa , Ethiopia

6. Rawalpindi Medical University Department of Neurosurgery, Holy Family Hospital, , Rawalpindi , Pakistan

7. University Malaya Faculty of Medicine, , Kuala Lumpur , Malaysia

8. Department of Neurosurgery, King Fahad Hospital , Al Jamiah, Kingdom o f Saudi Arabia

9. Muhimbili University of Health and Allied Sciences Department of Surgery, School of Medicine, , Dar es Salaam , Tanzania

Abstract

Abstract Managing sellar and suprasellar tumors is challenging due to their diverse origins and proximity to critical structures. The transsphenoidal surgical approach has become the preferred method, evolving from transcranial attempts to reduce morbidity. Microscopic transsphenoidal techniques have been refined over time, with endoscopic endonasal surgery emerging as a significant advancement. Due to the multifaceted nature of these approaches, the complexities of the pathology and the paucity of data from specific regions, understanding the prevalence, characteristics and management outcomes of sellar and suprasellar tumors is crucial for informing healthcare practices and resource allocation. This study aims to collate evidence-based insights into the efficacy of the endoscopic endonasal approach compared with the microscopic transsphenoidal approach as a surgical intervention for sellar and suprasellar tumors, following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines for 2020. To source pertinent information, we will rely on four primary central databases: PubMed, EMBASE, SCOPUS and the Cochrane Central Register of Controlled Trials. The primary outcome measure will be the surgical outcome’s effectiveness in achieving tumor resection and preserving pituitary function. The study protocol is duly registered with the International Prospective Register of Systematic Reviews (PROSPERO), with no requirement for ethical approval as it exclusively relies on previously published research. We aim to publish our findings in scientific journals and present the abstract at conferences to guide clinical practice. PROSPERO Registration Number: CRD42023461972: available via https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023461972.

Publisher

Oxford University Press (OUP)

Reference14 articles.

1. Management and outcomes of sellar, suprasellar and parasellar masses in low- and middle-income countries: a scoping review protocol;Egiz;J Surg Protoc Res Method,2022

2. Prevalence and characteristics of sellar masses in the city of Al Ain, United Arab Emirates: 2011 to 2016;Aldahmani;Ann Saudi Med,2020

3. Pituitary Tumors: background, pathophysiology, epidemiology,2022

4. Sellar and parasellar lesions: multidisciplinary management;Emanuelli;Acta Otorhinolaryngol Ital,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3